We posited that TNBC progression was independent of the IFN1 signaling but was mediated through NUPR1 packaged within cancer cell-derived EVs and that reserpine functioned in limiting NUPR1 packaging into EVs and suppressed NUPR1 expression in recipient cells treated with EVs. Here, NUPR1 is linked to cancer.